A randomized trial of unruptured brain arteriovenous malformations (ARUBA)

Acta Neurochirurgica, Supplementum

Volumn , Issue 103, 2008, Pages 3-4

  Mohr, J P ^a  

^a Department of Medicine   (United States)

Author keywords

Brain arteriovenous malformations; natural history

Indexed keywords

BRAIN ARTERIOVENOUS MALFORMATION; BRAIN HEMORRHAGE; CARDIOVASCULAR RISK; CONFERENCE PAPER; HUMAN; LONG TERM CARE; MORTALITY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; TREATMENT OUTCOME; ARTERIOVENOUS MALFORMATION; BRAIN DISEASE; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; REVIEW;

ARTERIOVENOUS MALFORMATIONS; BRAIN DISEASES; HUMANS; MULTICENTER STUDIES AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 85052608442     PISSN: 00651419     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-211-76589-0_1     Document Type: Conference Paper

References (21)

1. Achrol AS, Pawlikowska L, McCulloch CE, Poon KY, Ha C, Zaroff JG, Johnston SC, Lee C, Lawton MT, Sidney S, Marchuk DA, Kwok PY, Young WL, UCSF BAVM Study Project (2006) Tumor necrosis factor-alpha-238G>A promoter polymorphism is associated with increased risk of new hemorrhage in the natural course of patients with brain arteriovenous malformations. Stroke 37:231-234
2. Berman MF, Hartmann A, Mast H, Sciacca RR, Mohr JP, Pile-Spellman J, Young WL (1999) Determinants of resource utilization in the treatment of brain arteriovenous malformations. Am J Neuroradiol 20:2004-2008
3. Castel JP, Kantor G (2001) Postoperative morbidity and mortality after microsurgical exclusion of cerebral arteriovenous malformations. Current data and analysis of recent literature. Neurochirurgie 47:369-383
4. Chen Y, Fan Y, Poon KY, Achrol AS, Lawton MT, Zhu Y, McCulloch CE, Hashimoto T, Lee C, Barbaro NM, Bollen AW, Yang GY, Young WL (2006) MMP-9 expression is associated with leukocytic but not endothelial markers in brain arteriovenous malformations. Front Biosci 11:3121-3128
5. Chen Y, Pawlikowska L, Yao JS, Shen F, Zhai W, Achrol AS, Lawton MT, Kwok PY, Yang GY, Young WL (2006) Interleukin-6 involvement in brain arteriovenous malformations. Ann Neurol 59:72-80
6. Choi J M J, Sciacca RR, Hartmann A, Khaw AV, Mast H, Sacco RL, Stapf C (2006) Clinical outcome after first and subsequent hemorrhage in patients with untreated brain Arteriovenous malformations. Stroke (in press)
7. Choi JH, Mast H, Sciacca RR, Hartmann A, Khaw AV, Mohr JP, Sacco RL, Stapf C (2006) Clinical outcome after first and recurrent hemorrhage in patients with untreated brain arteriovenous malformation. Stroke 37:1243-1247
8. Choi JH, Mohr JP (2005) Brain arteriovenous malformations in adults. Review. Lancet Neurol 4:299-308
9. Hartmann A, Mast H, Mohr JP, Koennecke HC, Osipov A, Pile-Spellman J, Duong DH, Young WL (1998) Morbidityof intracranial hemorrhage in patients with cerebral arteriovenous malformation. Stroke 29:2001-2002
10. Hartmann A, Mast H, Mohr JP, Pil-Spellman J, Connolly ES, Sciacca RR, Khaw A, Stapf C (2005) Determinants of staged endovascular and surgical treatment outcome of brain arteriovenous malformations. Stroke 36:2431-2435
11. Hartmann A, Pile-Spellman J, Stapf C, Sciacca RR, Faulstich A, Moor JP, Schumacher HC, Mast H (2002) Risk of endovascular treatment of brain arteriovenous malformations. Stroke 33:1816-1820
12. Hashimoto T, Matsumoto MM, Li JF, Lawton MT, Young WL, University of California, San Francisco, BAVM Study Group (2005) Suppression of MMP-9 by doxycycline in brain arteriovenous malformations. BMC Neurol 5:1
13. Haw CS, terBrugge K, Willinsky R, Tomlinson G (2006) Complications of embolization of arteriovenous malformations of the brain. J Neurosurg 104:226-232
14. Hillman J (2001) Population-based analysis of arteriovenous malformation treatment. J Neurosurg 95:633-637
15. Lawton MT, Du R, Tran MN, Achrol AS, McCulloch CE, Johnston SC, Quinnine NJ, Young WL (2005) Effect of presenting hemorrhage on outcome after microsurgical resection of brain arteriovenous malformations. Neurosurgery 56:485-493
16. Mast H, Young WL, Koennecke HC, Sciacca RR, Osipov A, Pile-Spellman J, Hacein-Bey L, Duong H, Stein BM, Mohr JP (1997) Risk of spontaneous haemorrhage after diagnosis of cerebral arteriovenous malformation. Lancet 350:1065-1068
17. Ondra SL, Troupp H, George ED, Schwab K (1990) The natural history of symptomatic arteriovenous malformations of the brain: a 24-year follow-up assessment. J Neurosurg 73:387-391
18. Stapf C, Mast H, Sciacca RR, Berenstein A, Nelson PK, Gobin YP, Pile-Spellman J, Mohr JP, New York Islands Study Collaborators (2003) The New York Islands AVM Study: design, study progress, and initial results. Stroke 34: e29-e33
19. Stapf C, Mast H, Sciacca RR, Choi JH, Khaw AV, Connolly ES, Pile-Spellman J, Mohr JP (2006) Predictors of hemorrhage in patients with untreated brain arteriovenous malformation. Neurology 66:1350-1355
20. Stapf C, Mohr JP, Choi JH, Hartmann A, Mast H (2006) Invasive treatment of unruptured brain arteriovenous malformations is experimental therapy. Curr Opin Neurol 19:63-68
21. Sure U, Butz N, Siegel AM, Mennel HD, Bien S, Bertalanffy H (2001) Treatment-induced neoangiogenesis in cerebral arteriovenous malformations. Clin Neurol Neurosurg 103:29-32